Interleukin-17A inhibits adipocyte differentiation in human mesenchymal stem cells and regulates pro-inflammatory responses in adipocytes

Biochemical Pharmacology

Volumn 77, Issue 12, 2009, Pages 1835-1844

  Shin, Jennifer H ^a   Shin, Dong Wook ^b   Noh, Minsoo ^b  

^a Dep of Mechanical Engineering   (South Korea)

^b AmorePacific Corporation   (South Korea)

Author keywords

Adipocyte differentiation; Human bone marrow mesenchymal stem cells; IL 17A; Inflammation; Metabolic syndromes

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2; CYTOKINE ANTIBODY; IBUPROFEN; INTERLEUKIN 17; INTERLEUKIN 17 ANTIBODY; INTERLEUKIN 6; INTERLEUKIN 8; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROSTAGLANDIN E2; UNCLASSIFIED DRUG;

ADIPOCYTE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CELL DIFFERENTIATION; CONTROLLED STUDY; DRUG EFFECT; GENE EXPRESSION; HUMAN; HUMAN CELL; LIPOLYSIS; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; UPREGULATION;

ADIPOCYTES; CELL DIFFERENTIATION; CELLS, CULTURED; CYCLOOXYGENASE 2; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; INTERLEUKIN-17; INTERLEUKIN-6; INTERLEUKIN-8; LIPOLYSIS; MESENCHYMAL STEM CELLS; UP-REGULATION;

EID: 67349178585     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bcp.2009.03.008     Document Type: Article

References (45)

1. Dandona P., Aljada A., and Bandyopadhyay A. Inflammation: the link between insulin resistance, obesity and diabetes. Trends Immunol 25 (2004) 4-7
2. Shoelson S.E., Lee J., and Goldfine A.B. Inflammation and insulin resistance. J Clin Invest 116 (2006) 1793-1801
3. Hotamisligil G.S. Inflammation and metabolic disorders. Nature 444 (2006) 860-867
4. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J Clin Invest 115 (2005) 1111-1119
5. Shoelson S.E., Herrero L., and Naaz A. Obesity, inflammation, and insulin resistance. Gastroenterology 132 (2007) 2169-2180
6. Tilg H., and Moschen A.R. Inflammatory mechanisms in the regulation of insulin resistance. Mol Med 14 (2008) 222-231
7. Guilherme A., Virbasius J.V., Puri V., and Czech M.P. Adipocyte dysfunctions linking obesity to insulin resistance and type 2 diabetes. Nat Rev Mol Cell Biol 9 (2008) 367-377
8. Patton J.S., Shepard H.M., Wilking H., Lewis G., Aggarwal B.B., Eessalu T.E., et al. Interferons and tumor necrosis factors have similar catabolic effects on 3T3 L1 cells. Proc Natl Acad Sci USA 83 (1986) 8313-8317
9. Feingold K.R., Doerrler W., Dinarello C.A., Fiers W., and Grunfeld C. Stimulation of lipolysis in cultured fat cells by tumor necrosis factor, interleukin-1, and the interferons is blocked by inhibition of prostaglandin synthesis. Endocrinology 130 (1992) 10-16
10. Fried S.K., Bunkin D.A., and Greenberg A.S. Omental and subcutaneous adipose tissues of obese subjects release interleukin-6: depot difference and regulation by glucocorticoid. J Clin Endocrinol Metab 83 (1998) 847-850
11. Hotamisligil G.S., Shargill N.S., and Spiegelman B.M. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. Science 259 (1993) 87-91
12. Bruun J.M., Pedersen S.B., and Richelsen B. Regulation of interleukin 8 production and gene expression in human adipose tissue in vitro. J Clin Endocrinol Metab 86 (2001) 1267-1273
13. Kintscher U., Hartge M., Hess K., Foryst-Ludwig A., Clemenz M., Wabitsch M., et al. T-lymphocyte infiltration in visceral adipose tissue: a primary event in adipose tissue inflammation and the development of obesity-mediated insulin resistance. Arterioscler Thromb Vasc Biol 28 (2008) 1304-1310
14. Rocha V.Z., Folco E.J., Sukhova G., Shimizu K., Gotsman I., Vernon A.H., et al. Interferon-gamma, a Th1 cytokine, regulates fat inflammation: a role for adaptive immunity in obesity. Circ Res 103 (2008) 467-476
15. Heilbronn L.K., and Campbell L.V. Adipose tissue macrophages, low grade inflammation and insulin resistance in human obesity. Curr Pharm Des 14 (2008) 1225-1230
16. Naugler W.E., and Karin M. The wolf in sheep's clothing: the role of interleukin-6 in immunity, inflammation and cancer. Trends Mol Med 14 (2008) 109-119
17. Kimura A., Naka T., and Kishimoto T. IL-6-dependent and -independent pathways in the development of interleukin 17-producing T helper cells. Proc Natl Acad Sci USA 104 (2007) 12099-12104
18. Bettelli E., Korn T., and Kuchroo V.K. Th17: the third member of the effector T cell trilogy. Curr Opin Immunol 19 (2007) 652-657
19. Korn T., Oukka M., Kuchroo V., and Bettelli E. Th17 cells: effector T cells with inflammatory properties. Semin Immunol 19 (2007) 362-371
20. Chen Z., and O'Shea J.J. Th17 cells: a new fate for differentiating helper T cells. Immunol Res 41 (2008) 87-102
21. Kolls J.K., and Lindén A. Interleukin-17 family members and inflammation. Immunity 21 (2004) 467-476
22. Moseley T.A., Haudenschild D.R., Rose L., and Reddi A.H. Interleukin-17 family and IL-17 receptors. Cytokine Growth Factor Rev 14 (2003) 155-174
23. Wilson N.J., Boniface K., Chan J.R., McKenzie B.S., Blumenschein W.M., Mattson J.D., et al. Development, cytokine profile and function of human interleukin 17-producing helper T cells. Nat Immunol 8 (2007) 950-957
24. Ouyang W., Kolls J.K., and Zheng Y. The biological functions of T helper 17 cell effector cytokines in inflammation. Immunity 28 (2008) 454-467
25. Zrioual S., Toh M.L., Tournadre A., Zhou Y., Cazalis M.A., Pachot A., et al. IL-17RA and IL-17RC receptors are essential for IL-17A-induced ELR+ CXC chemokine expression in synoviocytes and are overexpressed in rheumatoid blood. J Immunol 180 (2008) 655-663
26. Ruddy M.J., Wong G.C., Liu X.K., Yamamoto H., Kasayama S., Kirkwood K.L., et al. Functional cooperation between interleukin-17 and tumor necrosis factor-alpha is mediated by CCAAT/enhancer-binding protein family members. J Biol Chem 279 (2004) 2559-2567
27. Kawaguchi M., Kokubu F., Kuga H., Matsukura H., Hoshino H., Ieki K., et al. Modulation of bronchial epithelial cells by IL-17. J Allergy Clin Immunol 108 (2001) 804-809
28. Liang S.C., Tan X.Y., Luxenberg D.P., Karim R., Dunussi-Joannopoulos K., Collins M., et al. Interleukin (IL)-22 and IL-17 are coexpressed by Th17 cells and cooperatively enhance expression of antimicrobial peptides. J Exp Med 203 (2006) 2271-2279
29. Pittenger M.F., Mackay A.M., Beck S.C., Jaiswal R.K., Douglas R., Mosca J.D., et al. Multilineage potential of adult human mesenchymal stem cells. Science 284 (1999) 143-147
30. Janderová L., McNeil M., Murrell A.N., Mynatt R.L., and Smith S.R. Human mesenchymal stem cells as an in vitro model for human adipogenesis. Obes Res 11 (2003) 65-74
31. Shin D.W., Kim S.N., Lee S.M., Lee W.J., Song M.J., Park S.M., et al. (-) catechin promotes adipocyte differentiation through PPARγ trasactivation. Biochem Pharmacol 77 (2009) 125-133
32. Pfaffl M.W. Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR. Nucleic Acids Res 29 (2001) 2002-2007
33. Silva Jr. W.A., Covas D.T., Panepucci R.A., Proto-Siqueira R., Siufi J.L., Zanette D.L., et al. The profile of gene expression of human marrow mesenchymal stem cells. Stem Cells 21 (2003) 661-669
34. Liotta F., Angeli R., Cosmi L., Filì L., Manuelli C., Frosali F., et al. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling. Stem Cells 26 (2008) 279-289
35. Raffaghello L., Bianchi G., Bertolotto M., Montecucco F., Busca A., Dallegri F., et al. Human mesenchymal stem cells inhibit neutrophil apoptosis: a model for neutrophil preservation in the bone marrow niche. Stem Cells 26 (2008) 151-162
36. Stamp L.K., Cleland L.G., and James M.J. Upregulation of synoviocyte COX-2 through interactions with T lymphocytes: role of interleukin 17 and tumor necrosis factor-alpha. J Rheumatol 31 (2004) 1246-1254
37. Kanda N., Koike S., and Watanabe S. IL-17 suppresses TNF-alpha-induced CCL27 production through induction of COX-2 in human keratinocytes. J Allergy Clin Immunol 116 (2005) 1144-1150
38. Vassaux G., Gaillard D., Darimont C., Ailhaud G., and Negrel R. Differential response of preadipocytes and adipocytes to prostacyclin and prostaglandin E2: physiological implications. Endocrinology 131 (1992) 2393-2398
39. Pacifico L., Di Renzo L., Anania C., Osborn J.F., Ippoliti F., Schiavo E., et al. Increased T-helper interferon-gamma-secreting cells in obese children. Eur J Endocrinol 154 (2006) 691-697
40. Schön M.P., and Boehncke W.H. Psoriasis. N Engl J Med 352 (2005) 1899-1912
41. Wright J.F., Guo Y., Quazi A., Luxenberg D.P., Bennett F., Ross J.F., et al. Identification of an interleukin 17F/17A heterodimer in activated human CD4+ T cells. J Biol Chem 282 (2007) 13447-13455
42. Toy D., Kugler D., Wolfson M., Vanden Bos T., Gurgel J., Derry J., et al. Cutting edge: interleukin 17 signals through a heteromeric receptor complex. J Immunol 177 (2006) 36-39
43. Wright J.F., Bennett F., Li B., Brooks J., Luxenberg D.P., Whitters M.J., et al. The human IL-17F/IL-17A heterodimeric cytokine signals through the IL-17RA/IL-17RC receptor complex. J Immunol 181 (2008) 2799-2805
44. Maione F., Pashalidis N., Mascolo N., Dufton N., Perretti M., and D'Acquisto F. Interleukin 17 sustains rather than induces inflammation. Biochem Pharmacol 77 (2009) 878-887
45. Subbaramaiah K., Hudis C., Chang S.H., Hla T., and Dannenberg A.J. EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange. J Biol Chem 283 (2008) 3433-3444